Pay in 4 interest-free payments of $5.63 Learn more
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28
Liang, J
10.1164/rccm.200212-1479SO
Shenkang injection and its three anthraquinones ameliorates renal fibrosis by simultaneous targeting IB/NF-B and keap1/nrf2 signaling pathways
6 weeks: 42 doses needed
The Phase 3 ophthalmic program (RGN-259) comprises three completed dry-eye trials (ARISE-1 n=317, ARISE-2 n=601, ARISE-3 n=700) and one completed European neurotrophic keratopathy trial (SEER-3), all of which missed their pre-specified primary endpoints
Account history views, flexible search filters, and pinned favorites can further personalize the experience
US$ 29.48
US$ 24.23
US$ 28.22
US$ 25.91
US$ 21.89
